Rocket Pharmaceuticals Market Sentiment

Rocket Pharmaceuticals Inc

RCKTNASDAQ

Trade with Public

$2.31

0.115%

마지막 업데이트: Oct 22, 4:00 PM

$2.31

0.115%

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Rocket Pharmaceuticals Market Sentiment - Benzinga

Rocket Pharmaceuticals Market Sentiment

Market sentiment signals for Rocket Pharmaceuticals (RCKT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 16.8% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

17 analysts

Options Flow (P/C)

—

Avg Consensus PT

+279.7%

Highest Price Target

$19

+722.5%

Scotiabank

Lowest Price Target

+8.2%

Jefferies

Short Interest

16.8%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 8, 2026	Goldman Sachs	Richard Law—	+73.2%	$3 → $4	Upgrade	Sell→Neutral
Oct 7, 2026	Leerink Partners	Roanna Ruiz—	+73.2%	$7 → $4	Maintained	Market Perform
Oct 7, 2026	Wedbush	Yun Zhong—	+549.4%	$15 → $15	Maintained	Outperform
Oct 7, 2026	Chardan Capital	Keay Nakae—	+376.2%	$11 → $11	Maintained	Buy
Sep 16, 2026	Wedbush	Yun Zhong—	+549.4%	$15 → $15	Maintained	Outperform
Sep 16, 2026	Needham	Gil Blum—	+289.6%	$9	Upgrade	Hold→Buy
Sep 15, 2026	Chardan Capital	Keay Nakae—	+376.2%	$11 → $11	Maintained	Buy
Sep 1, 2026	Chardan Capital	Keay Nakae—	+376.2%	$11 → $11	Maintained	Buy
Aug 11, 2026	Wedbush	Yun Zhong—	+549.4%	$16 → $15	Maintained	Outperform
May 11, 2026	Chardan Capital	Geulah Livshits—	+376.2%	$11 → $11	Maintained	Buy
Mar 30, 2026	B of A Securities	Jason Zemansky—	+289.6%	$8 → $9	Maintained	Buy
Mar 27, 2026	Chardan Capital	Geulah Livshits—	+376.2%	$11 → $11	Maintained	Buy
Mar 2, 2026	Goldman Sachs	Richard Law—	+29.9%	$2 → $3	Maintained	Sell
Feb 27, 2026	Cantor Fitzgerald	Josh Schimmer—	+332.9%	$8 → $10	Maintained	Overweight
Nov 18, 2025	B of A Securities	Jason Zemansky—	+246.3%	$10 → $8	Maintained	Buy
Nov 18, 2025	JP Morgan	Tessa Romero—	+11285.3%	$261 → $263	Downgrade	Overweight→Underweight
Oct 14, 2025	Chardan Capital	Geulah Livshits—	+376.2%	$11 → $11	Maintained	Buy
Oct 3, 2025	Leerink Partners	Mani Foroohar—	+203.0%	$9 → $7	Maintained	Market Perform
Aug 20, 2025	B of A Securities	Jason Zemansky—	+332.9%	$4 → $10	Upgrade	Neutral→Buy
Aug 20, 2025	Chardan Capital	Geulah Livshits—	+376.2%	$11 → $11	Maintained	Buy
Aug 11, 2025	Chardan Capital	Geulah Livshits—	+376.2%	$12 → $11	Maintained	Buy
Aug 8, 2025	Cantor Fitzgerald	Josh Schimmer—	+246.3%	$10 → $8	Maintained	Overweight
Jul 25, 2025	B of A Securities	Jason Zemansky—	+73.2%	$9 → $4	Downgrade	Buy→Neutral
Jul 25, 2025	Canaccord Genuity	Whitney Ijem—	+332.9%	$11 → $10	Maintained	Buy
Jul 24, 2025	Chardan Capital	Geulah Livshits—	+419.5%	$17 → $12	Maintained	Buy